BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21882492)

  • 1. A pilot study on the effects of carvedilol on right ventricular remodelling and exercise tolerance in patients with systemic right ventricle.
    Giardini A; Lovato L; Donti A; Formigari R; Gargiulo G; Picchio FM; Fattori R
    Int J Cardiol; 2007 Jan; 114(2):241-6. PubMed ID: 21882492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation between right ventricular structural alterations and markers of adverse clinical outcome in adults with systemic right ventricle and either congenital complete (after Senning operation) or congenitally corrected transposition of the great arteries.
    Giardini A; Lovato L; Donti A; Formigari R; Oppido G; Gargiulo G; Picchio FM; Fattori R
    Am J Cardiol; 2006 Nov; 98(9):1277-82. PubMed ID: 17056346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol.
    Khattar RS; Senior R; Soman P; van der Does R; Lahiri A
    Am Heart J; 2001 Oct; 142(4):704-13. PubMed ID: 11579363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Declining cardiopulmonary exercise capacity is not associated with worsening systolic systemic ventricular dysfunction in adults with transposition of great arteries after atrial switch operation.
    Roentgen P; Kaan M; Tutarel O; Meyer GP; Westhoff-Bleck M
    Congenit Heart Dis; 2014; 9(3):259-65. PubMed ID: 24034170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of carvedilol on ventriculo-arterial coupling in patients with heart failure.
    Razzolini R; Tarantini G; Boffa GM; Orlando S; Iliceto S
    Ital Heart J; 2004 Jul; 5(7):517-22. PubMed ID: 15487269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nonsystemic ventricular pacing in patients with transposition of the great arteries and atrial redirection.
    Horovitz A; De Guillebon M; van Geldorp IE; Bordachar P; Roubertie F; Iriart X; Douard H; Haissaguerre M; Thambo JB
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):766-70. PubMed ID: 22429270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of beta blockers (carvedilol or metoprolol XL) in patients with transposition of great arteries and dysfunction of the systemic right ventricle.
    Doughan AR; McConnell ME; Book WM
    Am J Cardiol; 2007 Mar; 99(5):704-6. PubMed ID: 17317376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
    Olsen SL; Gilbert EM; Renlund DG; Taylor DO; Yanowitz FD; Bristow MR
    J Am Coll Cardiol; 1995 May; 25(6):1225-31. PubMed ID: 7722114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of physical activity, cardiac function, exercise capacity, and quality of life in patients with a systemic right ventricle.
    Winter MM; Bouma BJ; van Dijk AP; Groenink M; Nieuwkerk PT; van der Plas MN; Sieswerda GT; Konings TC; Mulder BJ
    Am J Cardiol; 2008 Nov; 102(9):1258-62. PubMed ID: 18940303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of valsartan on systemic right ventricular function: a double-blind, randomized, placebo-controlled pilot trial.
    van der Bom T; Winter MM; Bouma BJ; Groenink M; Vliegen HW; Pieper PG; van Dijk AP; Sieswerda GT; Roos-Hesselink JW; Zwinderman AH; Mulder BJ
    Circulation; 2013 Jan; 127(3):322-30. PubMed ID: 23247302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.
    Hori M; Sasayama S; Kitabatake A; Toyo-oka T; Handa S; Yokoyama M; Matsuzaki M; Takeshita A; Origasa H; Matsui K; Hosoda S;
    Am Heart J; 2004 Feb; 147(2):324-30. PubMed ID: 14760332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved systemic ventricular function after carvedilol administration in a patient with congenitally corrected transposition of the great arteries.
    Lindenfeld J; Keller K; Campbell DN; Wolfe RR; Quaife RA
    J Heart Lung Transplant; 2003 Feb; 22(2):198-201. PubMed ID: 12581770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of carvedilol on right ventricular ejection fraction and cytokines levels in patients with systolic heart failure.
    Tatli E; Kurum T; Aktoz M; Buyuklu M
    Int J Cardiol; 2008 Apr; 125(2):273-6. PubMed ID: 18053592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right ventricular end-diastolic volume combined with peak systolic blood pressure during exercise identifies patients at risk for complications in adults with a systemic right ventricle.
    van der Bom T; Winter MM; Groenink M; Vliegen HW; Pieper PG; van Dijk AP; Sieswerda GT; Roos-Hesselink JW; Zwinderman AH; Mulder BJ; Bouma BJ
    J Am Coll Cardiol; 2013 Sep; 62(10):926-36. PubMed ID: 23850923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of carvedilol on left ventricular diastolic function and chamber volumes in advanced heart failure.
    Palazzuoli A; Quatrini I; Vecchiato L; Scali C; De Paola V; Iovine F; Martini G; Nuti R
    Minerva Cardioangiol; 2005 Aug; 53(4):321-8. PubMed ID: 16177676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentration of BNP, endothelin 1, pro-inflammatory cytokines (TNF-alpha, IL-6) and exercise capacity in patients with heart failure treated with carvedilol.
    Nessler J; Nessler B; Kitliński M; Gackowski A; Piwowarska W; Stepniewski M
    Kardiol Pol; 2008 Feb; 66(2):144-51; discussion 152-3. PubMed ID: 18344152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure.
    Metra M; Covolo L; Pezzali N; Zacà V; Bugatti S; Lombardi C; Bettari L; Romeo A; Gelatti U; Giubbini R; Donato F; Dei Cas L
    Cardiovasc Drugs Ther; 2010 Feb; 24(1):49-60. PubMed ID: 20352314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different impact of carvedilol and transdermal scopolamine on cardiovascular performance of mild-moderate chronic heart failure patients: evidence of useful effects of scopolamine on tolerance to work load.
    De Vecchis R; Pucciarelli G; Setaro A; Nocerino L
    Minerva Cardioangiol; 2000 Nov; 48(11):393-410. PubMed ID: 11214431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanical right ventricular dyssynchrony in patients after atrial switch operation for transposition of the great arteries.
    Chow PC; Liang XC; Lam WW; Cheung EW; Wong KT; Cheung YF
    Am J Cardiol; 2008 Mar; 101(6):874-81. PubMed ID: 18328857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.